[Pe-010] English Poster Session 010

[Pe-010-2] The design of LUMINESCE: A phase 3 trial of satralizumab in patients with gMG

Takamichi Sugimoto¹, Henry Kaminski², Chongbo Zhao³, Gerd Meyer Zu Horste⁴, Kevin C. O’Connor⁵, Gaelle Klingelschmitt⁶, Petranka Krumova⁶, Stuart Bolt⁷, Ivana Vodopivec⁶, Sian Lennon-Chrimes⁷, Hiroyuki Murai⁸ (1.Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Japan, 2.Department of Neurology & Rehabilitation Medicine, George Washington University SMHS, USA, 3.Department of Neurology, Huashan Hospital, Fudan University, China, 4.Department of Neurology, University Hospital of Munster, Germany, 5.Department of Neurology and Immunobiology, Yale University School of Medicine, USA, 6.F. Hoffmann-La Roche Ltd, Switzerland, 7.Roche Products Ltd, UK, 8.Department of Neurology, International University of Health and Welfare, Japan)